GSIS
ABBV icon

Global Strategic Investment Solutions’s AbbVie ABBV Stock Holding History

Global Strategic Investment Solutions’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$244K Sell
971
-3
-0.3% -$645 0.02% 138
2026
Q1 		$212K Sell
974
-1,420
-59% -$315K 0.02% 141
2025
Q4 		$547K Buy
2,394
+1
+0% +$228 0.05% 102
2025
Q3 		$554K Buy
+2,393
New +$487K 0.06% 101
2025
Q2 		– Sell
-1,102
Closed -$231K – 153
2025
Q1 		$231K Sell
1,102
-56
-5% -$10.9K 0.03% 137
2024
Q4 		$206K Sell
1,158
-141
-11% -$25.9K 0.02% 152
2024
Q3 		$257K Buy
+1,299
New +$242K 0.03% 133

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Global Strategic Investment Solutions's ABBV Position: Q2 2026 in Review

Global Strategic Investment Solutions reduced its AbbVie (ABBV) stake by 0.31% in Q2 2026, selling an estimated $645 and leaving 971 shares worth $244K. The position accounts for 0.02% of the portfolio, ranked #138.

Global Strategic Investment Solutions first reported a position in ABBV in Q3 2024 and has held it in 7 quarters since. The position peaked at $554K in Q3 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Global Strategic Investment Solutions held 971 shares of AbbVie worth $244K as of Q2 2026.
  • Global Strategic Investment Solutions sold 3 AbbVie shares in Q2 2026, an estimated $645.
  • AbbVie made up 0.02% of Global Strategic Investment Solutions's portfolio in Q2 2026, its #138 holding.
  • Global Strategic Investment Solutions first reported a position in AbbVie in Q3 2024 and has held it in 7 quarters since.
  • Global Strategic Investment Solutions's AbbVie position peaked at $554K in Q3 2025.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Global Strategic Investment Solutions's 13F filing for Q2 2026, filed 7 Aug 2026.